<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/multiparametric-magnetic-resonance-imaging-spectroscopy-and-multinuclear-23-na-imaging-monitoring/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/multiparametric-magnetic-resonance-imaging-spectroscopy-and-multinuclear-23-na-imaging-monitoring/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2010-11-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2010-11-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/multiparametric-magnetic-resonance-imaging-spectroscopy-and-multinuclear-23-na-imaging-monitoring/"},"url":"https://clinicaltree.github.io/posts/multiparametric-magnetic-resonance-imaging-spectroscopy-and-multinuclear-23-na-imaging-monitoring/"}</script><title>Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1291136400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Nov 30, 2010 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Michael A. Jacobs PhD</a> </em>, <em> <a href="">Vered Stearns MD</a> </em>, <em> <a href="">Antonio C. Wolff MD</a> </em>, <em> <a href="">Katarzyna Macura MD PhD</a> </em>, <em> <a href="">Pedram Argani MD</a> </em>, <em> <a href="">Nagi Khouri MD</a> </em>, <em> <a href="">Theodore Tsangaris MD</a> </em>, <em> <a href="">Peter B. Barker DPhil</a> </em>, <em> <a href="">Nancy E. Davidson MD</a> </em>, <em> <a href="">Zaver M. Bhujwalla PhD</a> </em>, <em> <a href="">David A. Bluemke MD PhD</a> </em>, <em> <a href="">Ronald Ouwerkerk PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2822 words"> <em>15 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The aim of this prospective study was to investigate using multiparametric and multinuclear magnetic resonance imaging during preoperative systemic therapy for locally advanced breast cancer.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Women with operable stage 2 or 3 breast cancer who received preoperative systemic therapy were studied using dynamic contrast-enhanced magnetic resonance imaging, magnetic resonance spectroscopy, and 23 Na magnetic resonance. Quantitative metrics of choline peak signal-to-noise ratio, total tissue sodium concentration, tumor volumes, and Response Evaluation Criteria in Solid Tumors were determined and compared to final pathologic results using receiver-operating characteristic analysis. Hormonal markers were investigated. Statistical significance was set at <em>P</em> &lt; .05.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Eighteen eligible women were studied. Fifteen responded to therapy, four (22%) with pathologic complete response and 11 (61%) with pathologic partial response. Three patients (17%) had no response. Among estrogen receptor–positive, HER2-positive, and triple-negative phenotypes, observed frequencies of pathologic complete response, pathologic partial response, and no response were 2, 5, and 0; 1, 4, and 0; and 1, 1, and 3, respectively. Responders (pathologic complete response and pathologic partial response) had the largest reductions in choline signal-to-noise ratio (35%, from 7.2 ± 2.3 to 4.6 ± 2; <em>P</em> &lt; .01) compared to nonresponders (11%, from 8.4 ± 2.7 to 7.5 ± 3.6; <em>P</em> = .13) after the first cycle. Total tissue sodium concentration significantly decreased in responders (27%, from 66 ± 18 to 48.4 ± 8 mmol/L; <em>P</em> = .01), while there was little change in nonresponders (51.7 ± 7.6 to 56.5 ± 1.6 mmol/L; <em>P</em> = .50). Lesion volume decreased in responders (40%, from 78 ± 78 to 46 ± 51 mm 3 ; <em>P</em> = .01) and nonresponders (21%, from 100 ± 104 to 79.2 ± 87 mm 3 ; <em>P</em> = .23) after the first cycle. The largest reduction in Response Evaluation Criteria in Solid Tumors occurred after the first treatment in responders (18%, from 24.5 ± 20 to 20.2 ± 18 mm; <em>P</em> = .01), with a slight decrease in tumor diameter noted in nonresponders (17%, from 23 ± 19 to 19.2 ± 19.1 mm; <em>P</em> = .80).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Multiparametric and multinuclear imaging parameters were significantly reduced after the first cycle of preoperative systemic therapy in responders, specifically, choline signal-to-noise ratio and sodium. These new surrogate radiologic biomarkers maybe able to predict and provide a platform for potential adaptive therapy in patients.</p><p>Breast cancer is a potentially curable disease, and the combined effects of early detection and adjuvant systemic therapy are likely the key elements that explain the observed reduction in breast cancer mortality over the past 20 years . The currently accepted standards for the detection and diagnosis of breast abnormalities are mammography, ultrasound, and magnetic resonance (MR) imaging (MRI) . If breast lesions are detected early, adjuvant systemic therapy after primary surgery reduces the risk for systemic recurrence or death . However, not all breast cancers are detected early, and some patients may present with stage 2 or 3 disease and require multimodality therapy. Preoperative systemic therapy (PST), also referred to as primary or neoadjuvant chemotherapy, is used to potentially reduce the size of the tumor and possibly convert a mastectomy to a lumpectomy in primary operable or locally advanced breast cancer . Perhaps of greater therapeutic implications, it may allow an early assessment of disease responsiveness and an opportunity to adjust therapy on the basis of observed response .</p><p>Pathologic response following PST appears to correlate with long-term outcome. National Surgical Adjuvant Bowel and Breast Project trial protocol B18 showed that approximately 12% of patients had pathologic complete response (pCR) with an anthracycline-based regimen (eg, doxorubicin and cyclophosphamide [AC]) , while the addition of four more cycles of a taxane in National Surgical Adjuvant Bowel and Breast Project trial protocol B27 doubled the pCR rate compared to AC alone . Patients who achieved pCR in these two studies had longer disease-free and overall survival . If this is confirmed, it implies that the early identification of those likely to respond to PST is of critical importance as a prognostic marker and to potentially allow midcourse adjustments in therapy. Thus, in vivo assessment before, during, and after PST may improve decision making and outcomes. Recent studies have demonstrated that in vivo assessments of therapeutic response are possible using MRI in patients who are undergoing PST . Partridge et al demonstrated that the use of dynamic contrast-enhanced (DCE) MRI could be predictive of outcome after a reduction in the size of the tumor in a recent American College of Radiology Imaging Network multi-institutional center trial. Messiamy et al reported that the use of MR spectroscopy (MRS) within 24 to 48 hours after the first cycle of therapy could detect cellular changes in total choline concentration within the tumor, and this has been confirmed by others . In addition, recent reports have demonstrated that the use of 23 Na MRI in patients with breast and other diseases provides additional metabolic information for diagnosis .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="clinical-subjects"><span class="mr-2">Clinical Subjects</span><a href="#clinical-subjects" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="pathologic-response-and-histologic-tissue-classification"><span class="mr-2">Pathologic Response and Histologic Tissue Classification</span><a href="#pathologic-response-and-histologic-tissue-classification" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-protocol"><span class="mr-2">MRI Protocol</span><a href="#mri-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="proton-mri"><span class="mr-2">Proton MRI</span><a href="#proton-mri" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="proton-mrs"><span class="mr-2">Proton MRS</span><a href="#proton-mrs" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="23--na-mri"><span class="mr-2">23 Na MRI</span><a href="#23--na-mri" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-image-preprocessing-and-analysis"><span class="mr-2">MR Image Preprocessing and Analysis</span><a href="#mr-image-preprocessing-and-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="lesion-and-volume-analysis"><span class="mr-2">Lesion and Volume Analysis</span><a href="#lesion-and-volume-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/0_1s20S1076633210004113.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/0_1s20S1076633210004113.jpg" alt="Figure 1, Representative three-dimensional visualization of dynamic contrast-enhanced magnetic resonance images after therapeutic intervention in a 54-year-old woman with T3N0M0 invasive ductal carcinoma of a large operable breast lesion. There was a steady reduction in tumor volume from baseline until surgery." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-spectroscopic-analysis"><span class="mr-2">MR Spectroscopic Analysis</span><a href="#mr-spectroscopic-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="quantitative--23--na-mri"><span class="mr-2">Quantitative 23 Na MRI</span><a href="#quantitative--23--na-mri" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="clinical-and-histopathologic-characteristics"><span class="mr-2">Clinical and Histopathologic Characteristics</span><a href="#clinical-and-histopathologic-characteristics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient Characteristics and Treatment Response ( <em>n</em> = 18)</p><p><a href="APKAICLNFGBCWWYGVIZQ" class="popup img-link "><img data-src="https://d1niluoi1dd30v.cloudfront.net/10766332/S1076633210X00113/S1076633210004113/fx1.jpg?Signature=UpznL34XxQ%7EWRM6XPRyfmJ--TNZhqoH447KhEll0M%7EQfQ8NMoql4RUYyJv%7E7z8QGHfeTReECtAs6PbFd9Bc9klupVVwNOMlb4Cin15TVqwl1jVWOsKrh1hrwBaZir%7EgiHgd6EuRfcyiUO-AsvychKyoOBBCiomEoGeRrNLO7Wm4_&amp;Expires=1669560819&amp;Key-Pair-Id=APKAICLNFGBCWWYGVIZQ" alt="" class="lazyload" data-proofer-ignore></a></p><p>AUC, area under the receiver-operating characteristic curve; DCE, dynamic contrast-enhanced; ER, estrogen receptor; FISH, fluorescence in situ hybridization; IHC, immunohistochemistry; PR, progesterone receptor; RECIST, Response Evaluation Criteria in Solid Tumors.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-response-and-pathology-findings-after-pst"><span class="mr-2">Clinical Response and Pathology Findings After PST</span><a href="#clinical-response-and-pathology-findings-after-pst" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="radiologic-metrics"><span class="mr-2">Radiologic Metrics</span><a href="#radiologic-metrics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="general"><span class="mr-2">General</span><a href="#general" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/1_1s20S1076633210004113.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/1_1s20S1076633210004113.jpg" alt="Figure 2, Demonstration of multiparametric and multinuclear magnetic resonance on a 54-year-old woman with T3N0M0 invasive ductal carcinoma receiving doxorubicin and cyclophosphamide followed by docetaxel chemotherapy. At baseline contrast MRI showed a large tumor volume with markedly increased choline level and total tissue sodium concentration. After treatment, there were steady reductions in choline signal-to-noise ratio, TSC, and tumor volumes beginning after the first cycle of treatment. At surgery, the patient was determined to have a pathologic complete response (pCR). MRS, magnetic resonance spectroscopy." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/2_1s20S1076633210004113.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/2_1s20S1076633210004113.jpg" alt="Figure 3, A representative 49-year-old postmenopausal woman with cT2N1M0 invasive ductal carcinoma who was receiving preoperative chemotherapy. (Left) Dynamic contrast-enhanced magnetic resonance imaging showed little or no reduction in tumor volume after treatment (Tx). (Middle) There was a visible choline peak at 3.2 ppm, which remained constant during the course of treatment. (Right) Similarly, there was little change in the sodium intensity and total tissue sodium concentration during the course of treatment. The patient’s final diagnosis was pathologic no response (pNR) with residual tumor present in the final surgical specimen. MRS, magnetic resonance spectroscopy." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="recist"><span class="mr-2">RECIST</span><a href="#recist" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mrs"><span class="mr-2">MRS</span><a href="#mrs" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/3_1s20S1076633210004113.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricMagneticResonanceImagingSpectroscopyandMultinuclear23NaImagingMonitoringofPreoperativeChemotherapyforLocallyAdvancedBreastCancer/3_1s20S1076633210004113.jpg" alt="Figure 4, Line plots of dynamic contrast-enhanced (DCE) volumes, choline signal-to-noise ratio (SNR), Response Evaluation Criteria in Solid Tumors (RECIST), and total sodium concentration (TSC) between responders (pathologic complete response and pathologic partial response) and nonresponders (pathologic no response) for complete preoperative systemic therapy in patients. The largest reductions in DCE MR, choline SNR, and TSC occurred after the first cycle in responders compared to nonresponders. Afterward, the reductions in DCE MR and choline SNR generally stabilized in both groups, whereas RECIST and TSC continued to decrease in responders until preoperative systemic therapy was completed and final surgery performed." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="23--na-mri-1"><span class="mr-2">23 Na MRI</span><a href="#23--na-mri-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="proton-dce-mr"><span class="mr-2">Proton DCE MR</span><a href="#proton-dce-mr" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="subgroup-analysis-between-pathologic-response-tumor-phenotype-and-imaging-findings"><span class="mr-2">Subgroup Analysis Between Pathologic Response, Tumor Phenotype, and Imaging Findings</span><a href="#subgroup-analysis-between-pathologic-response-tumor-phenotype-and-imaging-findings" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="tn-phenotype"><span class="mr-2">TN Phenotype</span><a href="#tn-phenotype" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="er-negative-progesterone-receptor-prnegative-and-her2-positive-phenotype"><span class="mr-2">ER-negative, Progesterone Receptor (PR)–negative, and HER2-positive Phenotype</span><a href="#er-negative-progesterone-receptor-prnegative-and-her2-positive-phenotype" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="er-positive-pr-positive-and-her2-negative-phenotype"><span class="mr-2">ER-positive, PR-positive, and HER2-negative Phenotype</span><a href="#er-positive-pr-positive-and-her2-negative-phenotype" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Jemal A., Siegel R., Ward E., et. al.: Cancer statistics, 2009. CA Cancer J Clin 2009; 59: pp. 225-249.</p><li><p>2. Lehman C.D., Gatsonis C., Kuhl C.K., et. al.: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: pp. 1295-1303.</p><li><p>3. El Khouli R.H., Jacobs M.A., Bluemke D.A.: Magnetic resonance imaging of the breast. Semin Roentgenol 2008; 43: pp. 265-281.</p><li><p>4. Early Breast Cancer Trialists’ Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: pp. 1687-1717.</p><li><p>5. Wolff A.C., Berry D., Carey L.A., et. al.: Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol 2008; 26: pp. 806-813.</p><li><p>6. Fisher B., Redmond C., Brown A., et. al.: Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. J Clin Oncol 1986; 4: pp. 459-471.</p><li><p>7. Fisher B., Redmond C., Wickerham D.L., et. al.: Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Ann Intern Med 1989; 111: pp. 703-712.</p><li><p>8. Kaufmann M., Hortobagyi G.N., Goldhirsch A., et. al.: Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 2006; 24: pp. 1940-1949.</p><li><p>9. Fisher B., Bryant J., Wolmark N., et. al.: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998; 16: pp. 2672-2685.</p><li><p>10. National Surgical Adjuvant Breast and Bowel Project: The effect on primary tumor response of adding sequential Taxotere to Adriamycin and cyclophosphamide: preliminary results from NSABP protocol B-27. Breast Cancer Res Treat 2001; 69: pp. 215.</p><li><p>11. Esserman L., Hylton N., Yassa L., et. al.: Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999; 17: pp. 110-119.</p><li><p>12. Partridge S.C., Gibbs J.E., Lu Y., et. al.: MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005; 184: pp. 1774-1781.</p><li><p>13. Yu H.J., Chen J.H., Mehta R.S., et. al.: MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging 2007; 26: pp. 615-623.</p><li><p>14. Meisamy S., Bolan P.J., Baker E.H., et. al.: Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy—a pilot study at 4 T. Radiology 2004; 233: pp. 424-431.</p><li><p>15. Manton D.J., Chaturvedi A., Hubbard A., et. al.: Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006; 94: pp. 427-435.</p><li><p>16. Kumar V., Jagannathan N.R., Kumar R., et. al.: Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging 2006; 24: pp. 541-548.</p><li><p>17. Baek H.M., Chen J.H., Nie K., et. al.: Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 2009; 251: pp. 653-662.</p><li><p>18. Jacobs M.A., Ouwerkerk R., Wolff A.C., et. al.: Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treat 2004; 3: pp. 543-550.</p><li><p>19. Ouwerkerk R., Jacobs M.A., Macura K.J., et. al.: Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive (23)Na MRI. Breast Cancer Res Treat 2007; 106: pp. 151-160.</p><li><p>20. Jacobs M.A., Ouwerkerk R., Kamel I., et. al.: Proton, diffusion-weighted imaging, and sodium ((23)Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging 2009; 29: pp. 649-656.</p><li><p>21. Bottomley P.A.: Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987; 508: pp. 333-348.</p><li><p>22. Jacobs M.A., Barker P.B., Bluemke D.A., et. al.: Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology 2003; 229: pp. 225-232.</p><li><p>23. Haase A., Frahm J., Hanicke W., et. al.: H-1-NMR chemical-shift selective (CHESS) imaging. Phys Med Biol 1985; 30: pp. 341-344.</p><li><p>24. Therasse P., Eisenhauer E.A., Verweij J.: RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 2006; 42: pp. 1031-1039.</p><li><p>25. Eisenhauer E.A., Therasse P., Bogaerts J., et. al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: pp. 228.</p><li><p>26. Jacobs M.A., Knight R.A., Windham J.P., et. al.: Identification of cerebral ischemic lesions in rat using eigenimage filtered magnetic resonance imaging. Brain Res 1999; 837: pp. 83-94.</p><li><p>27. Jacobs M.A., Barker P.B., Bottomley P.A., et. al.: Proton MR spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004; 19: pp. 68-75.</p><li><p>28. Baek H.M., Yu H.J., Chen J.H., et. al.: Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging 2008; 26: pp. 523-531.</p><li><p>29. Ouwerkerk R., Bleich K.B., Gillen J.S., et. al.: Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 2003; 227: pp. 529-537.</p><li><p>30. Ouwerkerk R., Weiss R.G., Bottomley P.A.: Measuring human cardiac tissue sodium concentrations using surface coils, adiabatic excitation, and twisted projection imaging with minimal T2 losses. J Magn Reson Imaging 2005; 21: pp. 546-555.</p><li><p>31. Hilal S.K., Maudsley A.A., Ra J.B., et. al.: In vivo NMR imaging of sodium-23 in the human head. J Comput Assist Tomogr 1985; 9: pp. 1-7.</p><li><p>32. Nagy I., Lustyik G., Lukacs G., et. al.: Correlation of malignancy with the intracellular Na+:K+ ratio in human thyroid tumors. Cancer Res 1983; 43: pp. 5395-5402.</p><li><p>33. Navon G.: Complete elimination of the extracellular 23Na NMR signal in triple quantum filtered spectra of rat hearts in the presence of shift reagents. Magn Reson Med 1993; 30: pp. 503-506.</p><li><p>34. Kline R.P., Wu E.X., Petrylak D.P., et. al.: Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging. Clin Cancer Res 2000; 6: pp. 2146-2156.</p><li><p>35. Winter P.M., Poptani H., Bansal N.: Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma. Cancer Res 2001; 61: pp. 2002-2007.</p><li><p>36. Babsky A.M., Topper S., Zhang H., et. al.: Evaluation of extra- and intracellular apparent diffusion coefficient of sodium in rat skeletal muscle: effects of prolonged ischemia. Magn Reson Med 2008; 59: pp. 485-491.</p><li><p>37. Pike M.M., Frazer J.C., Dedrick D.F., et. al.: 23Na and 39K nuclear magnetic resonance studies of perfused rat hearts. Discrimination of intra- and extracellular ions using a shift reagent. Biophys J 1985; 48: pp. 159-173.</p><li><p>38. Pekar J., Renshaw P.F., Leigh J.S.: Selective detection of intracellular sodium by coherence-transfer NMR. J Magn Reson 1987; 72: pp. 159-161.</p><li><p>39. Winter P.M., Bansal N.: Triple-quantum-filtered 23Na NMR spectroscopy of subcutaneously implanted 9L gliosarcoma in the rat in the presence of TmDOTP5-. J Magn Reson 2001; 152: pp. 70-78.</p><li><p>40. Tanase C., Boada F.E.: Triple-quantum-filtered imaging of sodium in presence of B(0) inhomogeneities. J Magn Reson 2005; 174: pp. 270-278.</p><li><p>41. Glunde K., Jacobs M.A., Pathak A.P., et. al.: Molecular and functional imaging of breast cancer. NMR Biomed 2009; 22: pp. 92-103.</p><li><p>42. Glunde K., Jacobs M.A., Bhujwalla Z.M.: Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 2006; 6: pp. 821-829.</p><li><p>43. Negendank W., Li C.W., Padavic-Shaller K., et. al.: Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies. Anticancer Res 1996; 16: pp. 1539-1544.</p><li><p>44. Soher B.J., van Zijl P.C., Duyn J.H., et. al.: Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996; 35: pp. 356-363.</p><li><p>45. Bolan P.J., Meisamy S., Baker E.H., et. al.: In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003; 50: pp. 1134-1143.</p><li><p>46. Baik H.M., Su M.Y., Yu H., et. al.: Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. Magma 2006; 19: pp. 96-104.</p><li><p>47. Fayad L.M., Salibi N., Wang X., et. al.: Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol 2010; 194: pp. W73-W79.</p><li><p>48. Woodhams R., Matsunaga K., Iwabuchi K., et. al.: Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005; 29: pp. 644-649.</p><li><p>49. El Khouli R.H., Macura K.J., Barker P.B., et. al.: Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging 2009; 30: pp. 999-1004.</p><li><p>50. Jin G., An N., Jacobs M.A., Li K.: The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol 2010; 17: pp. 456-463.</p><li><p>51. El Khouli R.H., Jacobs M.A., Macura K.J., et. al.: Diffusion weighted imaging improves the diagnostic accuracy of conventional breast MRI at 3 tesla. Radiology 2010; 256: pp. 64-73.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-17/'>Volume 17</a>, <a href='/categories/issue-12/'>Issue 12</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Multiparametric%20Magnetic%20Resonance%20Imaging,%20Spectroscopy%20and%20Multinuclear%20(23%20Na)%20Imaging%20Monitoring%20of%20Preoperative%20Chemotherapy%20for%20Locally%20Advanced%20Breast%20Cancer%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmultiparametric-magnetic-resonance-imaging-spectroscopy-and-multinuclear-23-na-imaging-monitoring%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Multiparametric%20Magnetic%20Resonance%20Imaging,%20Spectroscopy%20and%20Multinuclear%20(23%20Na)%20Imaging%20Monitoring%20of%20Preoperative%20Chemotherapy%20for%20Locally%20Advanced%20Breast%20Cancer%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmultiparametric-magnetic-resonance-imaging-spectroscopy-and-multinuclear-23-na-imaging-monitoring%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmultiparametric-magnetic-resonance-imaging-spectroscopy-and-multinuclear-23-na-imaging-monitoring%2F&text=Multiparametric%20Magnetic%20Resonance%20Imaging,%20Spectroscopy%20and%20Multinuclear%20(23%20Na)%20Imaging%20Monitoring%20of%20Preoperative%20Chemotherapy%20for%20Locally%20Advanced%20Breast%20Cancer%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-new-computerized-measurement-approach-of-carotid-artery-stenosis-on-tomographic-image-sequence/"><div class="card-body"> <em class="small" data-ts="1291136400" data-df="ll" > Nov 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A New Computerized Measurement Approach of Carotid Artery Stenosis on Tomographic Image Sequence</h3><div class="text-muted small"><p> Rationale and Objectives The stenosis degree of carotid artery (CA) can be a critical factor for treatment of cerebrovascular disease and for determining candidate of carotid endarterectomy. Curre...</p></div></div></a></div><div class="card"> <a href="/posts/a-text-to-speech-converter-for-radiology-journal-articles/"><div class="card-body"> <em class="small" data-ts="1291136400" data-df="ll" > Nov 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Text-to-Speech Converter for Radiology Journal Articles</h3><div class="text-muted small"><p> Radiology articles are primarily designed to be read on paper or a screen. Audio versions let users hear this material during activities when reading is not practical. Currently, there are relative...</p></div></div></a></div><div class="card"> <a href="/posts/an-interactive-web-based-tool-for-detecting-verification-work-up-bias-in-studies-of-the-efficacy-o/"><div class="card-body"> <em class="small" data-ts="1291136400" data-df="ll" > Nov 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>An Interactive Web-Based Tool for Detecting Verification (Work-up) Bias in Studies of the Efficacy of Diagnostic Imaging</h3><div class="text-muted small"><p> Rationale and Objectives Diagnostic tests are validated by comparison against a “gold standard” reference test. When the reference test is invasive or expensive, it may not be applied to all patie...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/mechanical-soft-tissue-property-validation-in-tissue-engineering-using-magnetic-resonance-imaging/" class="btn btn-outline-primary" prompt="Older"><p>Mechanical Soft Tissue Property Validation in Tissue Engineering Using Magnetic Resonance Imaging</p></a> <a href="/posts/patient-sedation-without-medication-rapid-rapport-and-quick-hypnotic-techniques-a-resource-guide-f/" class="btn btn-outline-primary" prompt="Newer"><p>Patient Sedation Without Medication Rapid Rapport and Quick Hypnotic Techniques A Resource Guide for Doctors, Nurses, and Technologists</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
